Source: ERJ Open Res, 3 (3) 00019-2016; 10.1183/23120541.00019-2016
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Akihiko Sokai, Kiminobu Tanizawa, Tomohiro Handa, Kumiko Kanatani, Takeshi Kubo, Kohei Ikezoe, Yoshinari Nakatsuka, Shinsaku Tokuda, Toru Oga, Toyohiro Hirai, Sonoko Nagai, Kazuo Chin, Michiaki Mishima. Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis. ERJ Open Res, 3 (3) 00019-2016; 10.1183/23120541.00019-2016

Member's Comments

No comment yet.

Related content which might interest you: Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Gender differences in serial pulmonary function testing in idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 579s Year: 2007 Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017 Year: 2017 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Plasma protein signature of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Extracellular matrix biomarkers predict change in lung function in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 Role of midkine in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Source: ERS Lung Science Conference 2021 Year: 2021 Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 204-212 Year: 2004 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Evaluating disease severity in idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017 Year: 2017 Changes in the small airways in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013